mesalamine has been researched along with Kidney Diseases in 19 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tubular proteinuria is an extra-intestinal manifestation of inflammatory bowel disease irrespective of 5-ASA treatment." | 2.70 | Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. ( Fraser, JS; Lamb, EJ; Muller, AF; Newman, DJ; Smith, DJ, 2001) |
| "A 29-year-old male patient with ulcerative colitis, who underwent haemodialysis thrice a week because of severe renal dysfunction." | 1.32 | Sulphasalazine-induced leucopenia in a patient with renal dysfunction. ( Hino, B; Iida, M; Itoh, Y; Joh, Y; Makino, K; Oishi, R; Teshima, D; Yano, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jairath, V | 1 |
| Hokkanen, SRK | 1 |
| Guizzetti, L | 1 |
| Boxall, N | 1 |
| Campbell-Hill, S | 1 |
| Patel, H | 1 |
| Moum, B | 1 |
| Velciov, S | 1 |
| Gluhovschi, G | 1 |
| Sporea, I | 1 |
| Trandafirescu, V | 1 |
| Petrica, L | 1 |
| Bozdog, G | 1 |
| Gluhovschi, C | 1 |
| Bob, F | 1 |
| Gădălean, F | 1 |
| Buzaş, R | 1 |
| Bobu, M | 1 |
| Voicu, L | 1 |
| Zallot, C | 1 |
| Billioud, V | 1 |
| Frimat, L | 1 |
| Faure, P | 1 |
| Peyrin-Biroulet, L | 1 |
| Teshima, D | 1 |
| Hino, B | 1 |
| Makino, K | 1 |
| Yano, T | 1 |
| Itoh, Y | 1 |
| Joh, Y | 1 |
| Iida, M | 1 |
| Oishi, R | 1 |
| Logan, RF | 2 |
| van Staa, TP | 1 |
| Siveke, JT | 1 |
| Egert, J | 1 |
| Sitter, T | 1 |
| Schiemann, U | 1 |
| Walcher, P | 1 |
| Török, HP | 1 |
| Glas, J | 1 |
| Folwaczny, C | 1 |
| Muller, AF | 2 |
| Stevens, PE | 1 |
| McIntyre, AS | 1 |
| Ellison, H | 1 |
| Gisbert, JP | 1 |
| González-Lama, Y | 1 |
| Maté, J | 1 |
| Briggs, D | 1 |
| Calder, I | 1 |
| Woods, R | 1 |
| Tange, J | 1 |
| Rhodes, J | 1 |
| Coles, GA | 1 |
| Sninsky, CA | 1 |
| Colombel, JF | 1 |
| Brabant, G | 1 |
| Gubler, MC | 1 |
| Locquet, A | 1 |
| Comes, MC | 1 |
| Dehennault, M | 1 |
| Delcroix, M | 1 |
| Kreisel, W | 1 |
| Wolf, LM | 1 |
| Grotz, W | 1 |
| Grieshaber, M | 1 |
| Schreiber, S | 1 |
| Hämling, J | 1 |
| Zehnter, E | 1 |
| Howaldt, S | 1 |
| Daerr, W | 1 |
| Raedler, A | 1 |
| Kruis, W | 1 |
| Elseviers, MM | 1 |
| De Broe, ME | 1 |
| Birketvedt, GS | 1 |
| Berg, KJ | 1 |
| Fausa, O | 1 |
| Florholmen, J | 1 |
| Fraser, JS | 1 |
| Smith, DJ | 1 |
| Newman, DJ | 1 |
| Lamb, EJ | 1 |
| Daneshmend, TK | 1 |
2 reviews available for mesalamine and Kidney Diseases
| Article | Year |
|---|---|
5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review.
Topics: Animals; Dose-Response Relationship, Drug; Humans; Inflammatory Bowel Diseases; Kidney; Kidney Disea | 2007 |
Epidemiology of toxic nephropathies.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Kidney Dis | 1997 |
1 trial available for mesalamine and Kidney Diseases
| Article | Year |
|---|---|
Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy.
Topics: Acetylglucosaminidase; Adult; Aged; Aged, 80 and over; Alpha-Globulins; Anti-Inflammatory Agents, No | 2001 |
16 other studies available for mesalamine and Kidney Diseases
| Article | Year |
|---|---|
No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Cohort Studies; Colitis, Ulcerative; Crohn Disease; D | 2019 |
Which are the 5-ASA compound side effects and how is it possible to avoid them?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; | 2008 |
Asymptomatic urinary anomalies, hematuria and proteinuria, in patients with inflammatory bowel disease. Preliminary study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Crohn Disease; Diagnosis, Diffe | 2011 |
5-Aminosalicylates and renal function monitoring in inflammatory bowel disease: a nationwide survey.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Creatinine; Cross-Sectional Studies; France; Gastroenterolo | 2013 |
Sulphasalazine-induced leucopenia in a patient with renal dysfunction.
Topics: Adult; Arylamine N-Acetyltransferase; Colitis, Ulcerative; Gastrointestinal Agents; Humans; Kidney D | 2003 |
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Topics: Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Data Interpretatio | 2003 |
5-ASA therapy and renal function in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammatory Bowel Diseases; Kidney Diseases; Mesal | 2005 |
Experience of 5-aminosalicylate nephrotoxicity in the United Kingdom.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Drug Monitoring; Epidemiolo | 2005 |
The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.
Topics: Acetaminophen; Aminophenols; Aminosalicylic Acids; Analgesics; Animals; Aspirin; Genetic Carrier Scr | 1982 |
An alternative view of 5-ASA formulations.
Topics: Aminosalicylic Acids; Chemistry, Pharmaceutical; Humans; Inflammatory Bowel Diseases; Kidney Disease | 1995 |
New salicylates as maintenance treatment in ulcerative colitis.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Humans; Kidney Diseases; Mesalamine | 1995 |
Renal insufficiency in infant: side-effect of prenatal exposure to mesalazine?
Topics: Adult; Aminosalicylic Acids; Crohn Disease; Female; Fetus; Humans; Infant; Kidney Diseases; Male; Me | 1994 |
Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, N | 1996 |
Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.
Topics: Adult; Alkaline Phosphatase; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Dose-Res | 1997 |
Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Kid | 2000 |
Mesalazine-associated thrombocytopenia.
Topics: Aminosalicylic Acids; Female; Headache; Humans; Kidney Diseases; Mesalamine; Middle Aged; Thrombocyt | 1991 |